The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Precuneus magnetic stimulation for Alzheimer’s disease: a randomized, sham-controlled trial
Open accessAbstract
Repetitive transcranial magnetic stimulation (rTMS) is emerging as a non-invasive therapeutic strategy in the battle against Alzheimer’s disease. Alzheimer’s disease patients primarily show alterations of the default mode network for which the precuneus is a key node. Here, we hypothesized that targeting the precuneus with TMS represents a promising strategy to slow down cognitive and functional decline in Alzheimer’s disease patients. We performed a randomized, double-blind, sham-controlled, phase 2, 24-week trial to determine the safety and efficacy of precuneus stimulation in patients with mild-to-moderate Alzheimer’s disease. Fifty Alzheimer’s disease patients were randomly assigned in a 1:1 ratio to either receive precuneus or sham rTMS (mean age 73.7 years; 52% female). The trial included a 24-week treatment, with a 2-week intensive course in which rTMS (or sham) was applied daily five times per week, followed by a 22-week maintenance phase in which stimulation was applied once weekly. The Clinical Dementia Rating Scale–Sum of Boxes was selected as the primary outcome measure, in which post-treatment scores were compared to baseline. Secondary outcomes included score changes in the Alzheimer’s Disease Assessment Scale–Cognitive Subscale, Mini-Mental State Examination and Alzheimer’s Disease Cooperative Study–Activities of Daily Living scale. Moreover, single-pulse TMS in combination with EEG was used to assess neurophysiological changes in precuneus cortical excitability and oscillatory activity. Our findings show that patients that received precuneus repetitive magnetic stimulation presented a stable performance of the Clinical Dementia Rating Scale–Sum of Boxes score, whereas patients treated with sham showed a worsening of their score. Compared with the sham stimulation, patients in the precuneus stimulation group also showed also significantly better performances for the secondary outcome measures, including the Alzheimer’s Disease Assessment Scale–Cognitive Subscale, Mini-Mental State Examination and Alzheimer’s Disease Cooperative Study–Activities of Daily Living scale. Neurophysiological results showed that precuneus cortical excitability remained unchanged after 24 weeks in the precuneus stimulation group, whereas it was significantly reduced in the sham group. Finally, we found an enhancement of local gamma oscillations in the group treated with precuneus stimulation but not in patients treated with sham. We conclude that 24 weeks of precuneus rTMS may slow down cognitive and functional decline in Alzheimer’s disease. Repetitive TMS targeting the default mode network could represent a novel therapeutic approach in Alzheimer’s disease patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · Brain and nerve · Cited by 21,038
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568
Scheltens, P., De Strooper, B., Kivipelto, M., Holstege, H., Chételat, G., Teunissen, C. E., Cummings, J., & van der Flier, W. M. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32205-4 · Cited by 5,465
The FAB: A frontal assessment battery at bedside
Dubois, B., Slachevsky, A., Litvan, I., & Pillon, B. (2000) · Neurology · doi:10.1212/wnl.55.11.1621 · Cited by 3,913
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Dubois, B., Feldman, H. H., Jacova, C., Hampel, H., Molinuevo, J. L., Blennow, K., DeKosky, S. T., Gauthier, S., Selkoe, D., Bateman, R., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70090-0 · Cited by 3,321
Lefaucheur, J.-P., Aleman, A., Baeken, C., Benninger, D. H., Brunelin, J., Di Lazzaro, V., Filipović, S. R., Grefkes, C., Hasan, A., Hummel, F. C., et al. (2020) · Clinical Neurophysiology · doi:10.1016/j.clinph.2019.11.002 · Cited by 2,382
Lefaucheur, J.-P., André-Obadia, N., Antal, A., Ayache, S. S., Baeken, C., Benninger, D. H., Cantello, R. M., Cincotta, M., de Carvalho, M., De Ridder, D., et al. (2014) · Clinical Neurophysiology · doi:10.1016/j.clinph.2014.05.021 · Cited by 2,119
Self-citationGamma frequency entrainment attenuates amyloid load and modifies microglia
Iaccarino, H. F., Singer, A. C., Martorell, A. J., Rudenko, A., Gao, F., Gillingham, T. Z., Mathys, H., Seo, J., Kritskiy, O., Abdurrob, F., et al. (2016) · Nature · doi:10.1038/nature20587 · Cited by 1,328
Deciphering the Molecular Basis of Memory Failure in Alzheimer's Disease
Walsh, D. M., & Selkoe, D. J. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.010 · Cited by 1,207
Donepezil for dementia due to Alzheimer’s disease.
Birks, J. S., & Harvey, R. J. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001190.pub3 · Cited by 1,200
An Inventory to Assess Activities of Daily Living for Clinical Trials in Alzheimerʼs Disease
Galasko, D., Bennett, D., Sano, M., Ernesto, C., Thomas, R., Grundman, M., & Ferris, S. (1997) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199700112-00005 · Cited by 1,194
Galasko, D. R., Bennett, D., Sano, M., Ernesto, C., Thomas, R., Grundman, M., & Ferris, S. H. (1997) · PubMed · Cited by 767
Rombouts, S. A. R. B., Barkhof, F., Goekoop, R., Stam, C. J., & Scheltens, P. (2005) · Human Brain Mapping · doi:10.1002/hbm.20160 · Cited by 734
Mohs, R. C., Knopman, D., Petersen, R. C., Ferris, S. H., Ernesto, C., Grundman, M., Sano, M., Bieliauskas, L., Geldmacher, D., Clark, C., et al. (1997) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199700112-00003 · Cited by 692
Alzheimer’s disease drug development pipeline: 2022
Cummings, J., Lee, G., Nahed, P., Kambar, M. E. Z. N., Zhong, K., Fonseca, J., & Taghva, K. (2022) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12295 · Cited by 665 · cited 1×
“41 On the other hand, changes in cognitive functions in other rTMS trials have been tested only with a few weeks of rTMS treatment.”
The road to restoring neural circuits for the treatment of Alzheimer's disease
Canter, R. G., Penney, J., & Tsai, L.-H. (2016) · Nature · doi:10.1038/nature20412 · Cited by 565
Brunoni, A. R., Chaimani, A., Moffa, A. H., Razza, L. B., Gattaz, W. F., Daskalakis, Z. J., & Carvalho, A. F. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.3644 · Cited by 520
Mohs, R. C., Knopman, D. S., Petersen, R. C., Ferris, S. H., Ernesto, C., Grundman, M., Sano, M., Bieliauskas, L. A., Geldmacher, D., Clark, C., et al. (1997) · PubMed · Cited by 487
Veitch, D. P., Weiner, M. W., Aisen, P. S., Beckett, L. A., Cairns, N. J., Green, R. C., Harvey, D., Jack, C. R., Jagust, W., Morris, J. C., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.08.005 · Cited by 454
Koch, G., Bonnì, S., Pellicciari, M. C., Casula, E. P., Mancini, M., Esposito, R., Ponzo, V., Picazio, S., Di Lorenzo, F., Serra, L., et al. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2017.12.048 · Cited by 367
Self-citationAndrews, J. S., Desai, U., Kirson, N. Y., Zichlin, M. L., Ball, D. E., & Matthews, B. R. (2019) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2019.06.005 · Cited by 338
Chou, Y.-H., Ton That, V., & Sundman, M. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.08.020 · Cited by 319
Ahmed, M. A., Darwish, E. S., Khedr, E. M., El serogy, Y. M., & Ali, A. M. (2012) · Journal of Neurology · doi:10.1007/s00415-011-6128-4 · Cited by 310
Improved language performance in Alzheimer disease following brain stimulation
Cotelli, M., Calabria, M., Manenti, R., Rosini, S., Zanetti, O., Cappa, S. F., & Miniussi, C. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.197848 · Cited by 304
Regional brain atrophy and functional disconnection across Alzheimer's disease evolution
Gili, T., Cercignani, M., Serra, L., Perri, R., Giove, F., Maraviglia, B., Caltagirone, C., & Bozzali, M. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.199935 · Cited by 285
Self-citationCotelli, M., Manenti, R., Cappa, S. F., Zanetti, O., & Miniussi, C. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02202.x · Cited by 264
Bai, F., Zhang, Z., Yu, H., Shi, Y., Yuan, Y., Zhu, W., Zhang, X., & Qian, Y. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.04.021 · Cited by 242
Cotelli, M., Borroni, B., Manenti, R., Alberici, A., Calabria, M., Agosti, C., Arévalo, A., Ginex, V., Ortelli, P., Binetti, G., et al. (2006) · Neuropsychology · doi:10.1037/0894-4105.20.5.558 · Cited by 224
Rapidly Progressive Alzheimer Disease
Schmidt, C., Wolff, M., Weitz, M., Bartlau, T., Korth, C., & Zerr, I. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.189 · Cited by 193
Disease progression meta‐analysis model in Alzheimer's disease
Ito, K., Ahadieh, S., Corrigan, B., French, J., Fullerton, T., Tensfeldt, T., & Alzheimer's Disease Working Group (2010) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2009.05.665 · Cited by 181
Kumar, S., Zomorrodi, R., Ghazala, Z., Goodman, M. S., Blumberger, D. M., Cheam, A., Fischer, C., Daskalakis, Z. J., Mulsant, B. H., Pollock, B. G., et al. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.3292 · Cited by 181
Sabbagh, M., Sadowsky, C., Tousi, B., Agronin, M. E., Alva, G., Armon, C., Bernick, C., Keegan, A. P., Karantzoulis, S., Baror, E., et al. (2020) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.08.197 · Cited by 167
Drumond Marra, H. L., Myczkowski, M. L., Maia Memória, C., Arnaut, D., Leite Ribeiro, P., Sardinha Mansur, C. G., Lancelote Alberto, R., Boura Bellini, B., Alves Fernandes da Silva, A., Tortella, G., et al. (2015) · Behavioural Neurology · doi:10.1155/2015/287843 · Cited by 162
Lin, Y., Zhu, M., & Su, Z. (2015) · Contemporary Clinical Trials · doi:10.1016/j.cct.2015.07.011 · Cited by 152
Rutherford, G., Lithgow, B., & Moussavi, Z. (2015) · Journal of Experimental Neuroscience · doi:10.4137/jen.s24004 · Cited by 126
Transcranial Magnetic Stimulation in Alzheimer’s Disease: Are We Ready?
Weiler, M., Stieger, K. C., Long, J. M., & Rapp, P. R. (2019) · eNeuro · doi:10.1523/eneuro.0235-19.2019 · Cited by 122
Yokoi, T., Watanabe, H., Yamaguchi, H., Bagarinao, E., Masuda, M., Imai, K., Ogura, A., Ohdake, R., Kawabata, K., Hara, K., et al. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00304 · Cited by 116
Casula, E. P., Pellicciari, M. C., Bonnì, S., Spanò, B., Ponzo, V., Salsano, I., Giulietti, G., Cinnera, A. M., Maiella, M., Borghi, I., et al. (2021) · Human Brain Mapping · doi:10.1002/hbm.25297 · Cited by 109
Self-citationColey, N., Andrieu, S., Jaros, M. J., Weiner, M. W., Cedarbaum, J. M., & Vellas, B. J. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.01.005 · Cited by 107
Nguyen, J., Suarez, A., Kemoun, G., Meignier, M., Saout, E. L., Damier, P., Nizard, J., & Lefaucheur, J. (2017) · Neurophysiologie Clinique · doi:10.1016/j.neucli.2017.01.001 · Cited by 95
Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer’s disease
Strom, A., Iaccarino, L., Edwards, L., Lesman-Segev, O. H., Soleimani-Meigooni, D. N., Pham, J., Baker, S. L., Landau, S. M., Jagust, W. J., Miller, B. L., et al. (2022) · Brain · doi:10.1093/brain/awab294 · Cited by 91
ENGAGE and EMERGE: Truth and consequences?
Kuller, L. H., & López, O. L. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12286 · Cited by 90
TMS evidence for a selective role of the precuneus in source memory retrieval
Bonnì, S., Veniero, D., Mastropasqua, C., Ponzo, V., Caltagirone, C., Bozzali, M., & Koch, G. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.12.032 · Cited by 84
Self-citationLongitudinal Changes in Functional Brain Connectivity Predicts Conversion to Alzheimer’s Disease
Serra, L., Cercignani, M., Mastropasqua, C., Torso, M., Spanò, B., Makovac, E., Viola, V., Giulietti, G., Marra, C., Caltagirone, C., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150961 · Cited by 81
Self-citationCognitive trajectory in mild cognitive impairment due to primary age-related tauopathy
Teylan, M., Mock, C., Gauthreaux, K. M., Chen, Y., Chan, K. C. G., Hassenstab, J. J., Besser, L. M., Kukull, W. A., & Crary, J. F. (2019) · Brain · doi:10.1093/brain/awz403 · Cited by 69
Koch, G., Motta, C., Bonnì, S., Pellicciari, M. C., Picazio, S., Casula, E. P., Maiella, M., Lorenzo, F. D., Ponzo, V., Ferrari, C., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.10372 · Cited by 64
Self-citationChoung, J. S., Kim, J., Ko, M.-H., Cho, D. S., & Kim, M. (2021) · Scientific Reports · doi:10.1038/s41598-020-80147-x · Cited by 59
Nellessen, N. D., Rottschy, C., Eickhoff, S. B., Ketteler, S. T., Kuhn, H., Shah, N. J., Schulz, J. B., Reske, M., & Reetz, K. (2014) · Brain Structure and Function · doi:10.1007/s00429-014-0744-6 · Cited by 50
Tchalla, A. E., Clément, J., Saulnier, I., Beaumatin, B., Lachal, F., Gayot, C., Bosetti, A., Désormais, I., Perrochon, A., Preux, P., et al. (2018) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000487938 · Cited by 46
Mancini, M., Mastropasqua, C., Bonnì, S., Ponzo, V., Cercignani, M., Conforto, S., Koch, G., & Bozzali, M. (2017) · Brain Topography · doi:10.1007/s10548-017-0559-x · Cited by 31
Self-citationSynaptic impairment: The new battlefield of Alzheimer's disease
Francesco, D. L., & Koch, G. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12189 · Cited by 30
Self-citationNguyen, J., Suarez, A., Saout, E. L., Meignier, M., Nizard, J., & Lefaucheur, J. (2018) · Brain stimulation · doi:10.1016/j.brs.2018.02.013 · Cited by 24
Cited by
The functional role of the precuneus
Dadario, N. B., & Sughrue, M. E. (2023) · Brain · doi:10.1093/brain/awad181 · Cited by 319
Zhukovsky, P., Coughlan, G., Buckley, R., Grady, C., & Voineskos, A. N. (2023) · Human Brain Mapping · doi:10.1002/hbm.26148 · Cited by 26
Li, S., Lan, X., Liu, Y., Zhou, J., Pei, Z., Su, X., & Guo, Y. (2024) · Journal of Alzheimer’s Disease · doi:10.3233/jad-231031 · Cited by 24
Metadata
- Authors
- Koch, G., Casula, E. P., Bonnì, S., Borghi, I., Assogna, M., Minei, M., Pellicciari, M. C., Motta, C., D’Acunto, A., Porrazzini, F., Maiella, M., Ferrari, C., Caltagirone, C., Santarnecchi, E., Bozzali, M., & Martorana, A.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2022-10-25
- Volume
- 145
- Issue
- 11
- Pages
- 3776-3786
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W4307198180
- Cited by
- 259
- References
- 54
- FWCI
- 14.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.